Daliresp (Roflumilast) — Patient Guide (Australia)
Daliresp contains roflumilast, a medicine used to help manage certain long-term lung conditions associated with chronic inflammation and airflow limitation. This guide explains how Daliresp works, how it is usually taken, what to expect, and important safety information for people in Australia.
Always follow the dosing schedule provided with your medicine. If you have questions about your specific situation, speak with a healthcare professional.
At a glance
- Generic name: Roflumilast
- Brand name: Daliresp
- Medicine type: Phosphodiesterase-4 (PDE4) inhibitor
- Common purpose: Reducing flare-ups in specific types of severe chronic obstructive pulmonary disease (COPD)
- Typical dosing frequency: Once daily
- Key safety notes: Possible weight loss, gastrointestinal side effects, mood changes; caution in certain liver conditions
Basic product information
Daliresp (roflumilast) is an anti-inflammatory medicine delivered as tablets for oral use. It is intended for long-term management of lung disease rather than quick relief of sudden breathing attacks.
Strengths: Daliresp is commonly available in Australia in tablet strengths such as 250 micrograms and 500 micrograms (availability can vary by supplier).
Who it’s for: People with moderate to severe COPD who are at higher risk of flare-ups, particularly those with a history of exacerbations and chronic bronchitis features (cough with mucus).
How Daliresp works (mechanism of action)
Roflumilast works by blocking an enzyme called phosphodiesterase-4 (PDE4).
- PDE4 normally breaks down cyclic adenosine monophosphate (cAMP) inside certain inflammatory cells.
- By inhibiting PDE4, roflumilast helps increase cAMP and reduce inflammatory signalling.
- This can lead to reduced airway inflammation, including a decrease in inflammatory mediators that contribute to COPD symptoms and exacerbation risk.
What it does not do: Daliresp is not a “rescue” inhaler or fast-acting bronchodilator. Its benefits develop over time as inflammation reduces.
Pharmacokinetics (how the body handles it)
Absorption: Roflumilast is absorbed after oral administration. Taking it consistently is important.
Active metabolite: In the body, roflumilast is metabolised primarily in the liver to an active metabolite (roflumilast N-oxide), which contributes to the overall effect.
Onset: Improvement is typically not immediate. Many people notice benefits over weeks rather than hours.
Half-life (duration of action): Roflumilast and its metabolite have long-lasting effects, supporting once-daily dosing.
Elimination: The medicine and its metabolites are cleared mainly through metabolism and excretion (predominantly via the kidneys and/or with bile). Exact proportions vary between individuals.
Liver considerations: Because metabolism occurs in the liver, roflumilast requires caution in people with liver impairment.
Typical use in COPD
In Australia, Daliresp is used as an add-on treatment for selected adults with severe COPD and chronic bronchitis, especially those who have a history of frequent exacerbations (flare-ups).
It is usually considered alongside other core COPD therapies, such as:
- Inhaled maintenance treatments (e.g., long-acting bronchodilators)
- Inhaled corticosteroids for appropriate patients
- Short-acting “reliever” medicines for sudden symptom worsening
Not for acute attacks: If you have sudden worsening breathlessness, you should use your prescribed reliever plan immediately and seek urgent help if severe.
Indications (when it may be used)
Daliresp is indicated for the prevention of COPD exacerbations in appropriate adults with severe COPD associated with chronic bronchitis and frequent exacerbations, particularly those with a history suggesting an inflammatory bronchitis component.
Local prescribing practices may vary. Australia’s respiratory guidelines and product information can influence who is selected and how treatment is structured.
Dosing and timing
How often: Usually taken once daily.
Starting dose and adjustment: Some treatment plans start with a lower strength to reduce side effects, then increase to the maintenance dose if tolerated. Your healthcare professional will advise the exact schedule.
Timing of your dose: Try to take it at the same time each day. Many people choose the evening or a consistent time that fits their routine. If you experience nausea or dizziness, adjusting the time may help—discuss options with your healthcare provider.
How to take:
- Swallow the tablet whole with water.
- Do not crush or chew unless instructed.
- If you miss a dose, take it when you remember unless it is close to your next dose. If it’s close, skip the missed dose—do not double up.
How long to wait for benefit: COPD prevention and inflammation control may take time. If you do not notice improvement after starting, continue as directed and allow time—while also reviewing side effects with your clinician.
Food interactions
Can you take Daliresp with food? Daliresp can generally be taken with or without food. However, individual tolerance matters.
- If you experience nausea, stomach pain, or diarrhoea, taking it with food may improve comfort.
- Maintain consistency: taking with food daily may be easier for your stomach than switching.
Weight loss and appetite: Roflumilast can reduce appetite and lead to weight loss. If you notice reduced hunger, consider nutrient-dense meals and speak with your healthcare team early.
Alcohol and medicine interactions
Alcohol
There is no “one-size-fits-all” rule that alcohol is absolutely forbidden. However:
- Alcohol may worsen dizziness, nausea, or sleep-related effects
- In people with underlying liver issues or heavier alcohol intake, extra caution is recommended
Practical approach: If you drink alcohol, keep it moderate, monitor how you feel after taking your dose, and avoid binge drinking. Discuss your alcohol pattern with your healthcare professional, particularly if you have liver concerns.
Medicine interactions (examples)
Roflumilast is metabolised in the liver. Some medicines can affect its metabolism or increase side-effect risk. Inform your healthcare professional about all medicines and supplements, including:
- Medicines that strongly affect liver enzymes (some antibiotic and anti-seizure medicines can alter metabolism)
- Other anti-inflammatory or COPD medicines (usually compatible, but confirm your specific regimen)
- Medicines associated with weight loss, mood changes, or GI side effects (may increase tolerability concerns)
Do not start or stop any medicine without advice. Drug interaction risk depends on your full medication list and health history.
Herbal supplements: Some supplements can also affect liver enzymes. Check with a pharmacist before using products such as St John’s wort or “liver support” blends.
Safety profile and who needs extra caution
Common side effects
Most side effects are related to the digestive system or overall tolerance.
- Diarrhoea
- Nausea
- Abdominal pain
- Weight loss or reduced appetite
- Headache
- Dizziness
- Sleep disturbance (in some people)
Serious but less common risks
- Mood changes, including depression, anxiety, or suicidal thoughts—seek urgent help if you experience these
- Severe allergic reactions (rare): swelling, rash, breathing difficulty
- Severe diarrhoea or signs of dehydration
- Worsening of liver-related problems: roflumilast needs caution in liver impairment
When to seek urgent medical help
Seek urgent care if you develop:
- Signs of a serious allergic reaction (swelling of face/lips, trouble breathing)
- Severe or persistent diarrhoea with light-headedness, fainting, or signs of dehydration
- New or worsening depression, suicidal thoughts, or severe behavioural changes
- Yellowing of eyes/skin (jaundice) or severe abdominal pain suggesting a liver problem
Who should be extra careful
- People with a history of depression or mood disorders
- People who are underweight or prone to weight loss
- People with liver impairment (your prescriber will evaluate suitability)
- People with significant gastrointestinal sensitivity
Practical use tips (making treatment easier)
1) Monitor weight and appetite
Weight loss is one of the more important tolerability concerns. Consider:
- Weighing yourself regularly (for example, weekly) if you are at risk
- Keeping track of appetite changes
- Discussing early if weight drops—your plan may need adjustment
2) Manage stomach side effects
- Take consistently and consider with food if nausea or stomach discomfort occurs
- Stay hydrated, especially if diarrhoea occurs
- Avoid very fatty or heavy meals if these worsen symptoms
3) Watch your mood
- Tell your healthcare professional if you have depression/anxiety
- Involve a family member or caregiver if appropriate, so changes can be noticed early
- Seek help promptly if mood symptoms intensify
4) Don’t use it as a rescue medicine
- Keep using your reliever inhaler/plan as directed
- If your breathing worsens quickly, follow your action plan and seek urgent help
5) Take it at the same time daily
Routine dosing supports consistent anti-inflammatory action and may improve tolerability.
Alternative options for COPD prevention (overview)
If Daliresp is not suitable or not tolerated, clinicians may consider other strategies depending on your COPD severity and exacerbation history.
Common alternatives/adjuncts may include:
- Optimising inhaled therapy (long-acting bronchodilators, inhaled corticosteroids when indicated)
- Smoking cessation support (often the most impactful step)
- Pulmonary rehabilitation to improve exercise tolerance and reduce symptoms
- Vaccinations (influenza, pneumococcal, and others as recommended)
- Other COPD medicines used to prevent exacerbations in selected patients (choice depends on your profile)
Your best alternative depends on: your exacerbation frequency, symptom pattern (especially chronic bronchitis features), oxygen needs, blood eosinophil levels, comorbidities, and tolerability.
Pharmacovigilance and Australian market/legal context
In Australia, medicines are regulated by the Therapeutic Goods Administration (TGA). Brand availability, indications, and product information can change over time.
Product listing and prescribing details: The exact information relevant to the Australian market is set out in the official product information and consumer medicines information (CMI) materials. Always check that you have the correct strength and product form from your supplier.
Prescription vs. supply: Depending on the local supply arrangements and your circumstances, access to Daliresp may involve professional assessment and monitoring. Availability through online pharmacies should comply with Australian laws and pharmacy standards.
Recent guidance (what to know)
While treatment guidelines are updated periodically, the overall themes in COPD management generally include:
- Use maintenance bronchodilator therapy as the foundation
- Consider exacerbation prevention strategies for people with frequent flare-ups
- Assess comorbidities and medication tolerability (including weight loss and mood)
- Ensure inhaler technique, adherence, and smoking cessation support
For Daliresp specifically: clinicians typically review potential benefits against side effects, especially in people who are underweight or have psychiatric history. Your care team may also monitor weight and symptoms more closely after starting or changing dose.
Note: Guidance and eligibility criteria may evolve. For the latest information, refer to current Australian COPD guidance from reputable clinical bodies and your healthcare professional.
Delivery and availability in Australia
Online pharmacies in Australia may offer home delivery for many medicines, subject to:
- Stock availability and pharmacy fulfilment schedules
- Correct prescription/documentation requirements (as applicable)
- Packaging and temperature/storage conditions (if required)
- Address eligibility and identity verification steps
Delivery expectations: Delivery times vary by postcode and courier service. You’ll typically receive tracking information once your order is dispatched.
Storage at home: Store tablets at controlled room temperature (unless otherwise stated on the pack), keep them in the original packaging, and keep out of reach of children.
FAQ — Common questions about Daliresp (Roflumilast)
1) Is Daliresp a reliever for sudden breathlessness?
No. Daliresp is used to help prevent COPD exacerbations by reducing inflammation. It is not a rescue medicine. Use your reliever inhaler and follow your COPD action plan for sudden worsening symptoms.
2) How soon will I feel better?
Benefits often take weeks. Some people may notice changes earlier, while others require more time. If side effects are severe, contact your healthcare professional rather than stopping abruptly unless advised.
3) Should I take it with food?
Many people tolerate Daliresp better with food, especially if they experience nausea or stomach discomfort. If you already have a routine, keep it consistent.
4) Can I drink alcohol while taking Daliresp?
Moderation is generally sensible. Alcohol may worsen dizziness, nausea, sleep issues, or dehydration risk—especially if you’re already dealing with diarrhoea. Discuss your alcohol intake with a healthcare professional, particularly if you have liver concerns.
5) What are the most important side effects to watch?
The most notable include weight loss, diarrhoea, nausea, and mood changes. Seek urgent help if you develop severe diarrhoea/dehydration signs or significant mood changes.
6) What should I do if I miss a dose?
If you remember soon after, you may take it. If it is close to the next dose, skip the missed one. Do not double the dose. If unsure, ask your pharmacist.
7) Will Daliresp cause weight loss?
It can, particularly by reducing appetite. Monitoring is important—especially if you are already underweight. If you notice rapid or concerning weight loss, contact your healthcare professional promptly.
8) Can Daliresp affect mood or sleep?
Some people report mood changes, including depression or anxiety, and sleep disturbances. If you notice changes in mood, behaviour, or thoughts of self-harm, get urgent medical help.
9) Are there medicine interactions?
Yes. Because roflumilast is metabolised in the liver, some medicines can affect levels or side-effect risk. Always provide your complete medication list to your healthcare professional and pharmacist, including herbal supplements.
10) Who should not take Daliresp?
Suitability depends on your medical history, especially liver function, mood history, gastrointestinal tolerance, and current COPD treatment. Your healthcare professional can confirm whether it is appropriate for you.
Summary
Daliresp (roflumilast) is a long-term COPD medicine that helps prevent flare-ups by reducing inflammatory pathways through PDE4 inhibition. It is taken once daily and may be used in selected people with severe COPD and chronic bronchitis who are at increased risk of exacerbations. The most important practical considerations include monitoring for weight loss, managing gastrointestinal side effects, and watching for mood changes. If you have concerns or side effects, speak with your healthcare professional to adjust your care plan.
| Feature | What to know |
|---|---|
| Brand / Generic | Daliresp / Roflumilast |
| Use | Helps prevent COPD exacerbations in selected severe COPD patients with chronic bronchitis features |
| How it works | PDE4 inhibitor → reduces inflammatory signalling |
| Typical dosing | Once daily (dose may be started lower and increased depending on tolerance) |
| With food? | Generally can be taken with or without food; with food may reduce nausea |
| Alcohol | Use caution—may worsen dizziness/nausea; discuss with your clinician especially if liver issues |
| Key side effects | Diarrhoea, nausea, abdominal pain, weight loss, headache, dizziness; watch mood changes |
| Not for | Sudden breathing attacks (not a rescue medicine) |
Disclaimer: This information is a general guide for patients and is not a substitute for professional medical advice. If you have questions about suitability, interactions, or side effects, consult a healthcare professional or pharmacist.
